ClinicalTrials.Veeva

Menu

Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.

I

Israel Healthcare Foundation

Status and phase

Enrolling
Phase 3

Conditions

Peritoneal Dialysis Complication
Peritoneal Dialysis-associated Peritonitis
Peritoneal Dialysis Catheter Infection

Treatments

Drug: Cefazolin

Study type

Interventional

Funder types

Other

Identifiers

NCT03046511
CMC-16-0067-CTIL

Details and patient eligibility

About

An intraperitoneal implanted catheter is always necessary to perform Peritoneal Dialysis. Catheter insertion has been associated with infectious complication such as Exit Site Infection (ESI), Tunnel Infection and Peritonitis. The last one may lead to loss of the technique because the need of catheter removal. Most of international guidelines recommends the use of prophylactic antibiotics. Different protocols has been used, mostly intravenous single injection before the procedure. For the last 25 years our unit gives a single intraperitoneal dose of Cefazolin immediately after the catheter insertion. The aim of this study is compare the effect of a pre- operative IV dose os Cefazolin with a post- procedure intraperitoneal single dose administration of the same drug.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subjects suffering from Chronic Kidney Disease, candidates to a intra- peritoneal catheter insertion

Exclusion criteria

Pregnancy; Active antibiotic treatment before the procedure; Known allergy to Cefazolin

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 2 patient groups

Intraperitoneal
Experimental group
Description:
One single dose of intraperitoneal Cefazolin 1000 mg via the recently inserted peritoneal catheter
Treatment:
Drug: Cefazolin
Intravenous
Active Comparator group
Description:
One single dose of intravenous Cefazolin 1000 mg one hour before catheter insertion
Treatment:
Drug: Cefazolin

Trial contacts and locations

1

Loading...

Central trial contact

Victor Frajewicki, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems